Aug 14 (Reuters)-
Cyfuse Biomedical K.K.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2025 Jun 30, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 29 mln 18 mln 302 mln
(+63.1 pct) (-1.3 pct) (+455.8 pct)
Operating loss 471 mln loss 448 mln loss 1.22
Recurring loss 401 mln loss 445 mln loss 1.14
Net loss 402 mln loss 447 mln loss 1.14
EPS loss 48.86 yen loss 56.15 yen loss 139.64 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Cyfuse Biomedical K.K..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T